OCULAR THERAPEUTIX, INC

OCUL · Nasdaq · SIC 2834: Pharmaceutical Preparations
236
SEC Filings

Business Summary

PART I We are an integrated biopharmaceutical company committed to redefining the retina experience. AXPAXLI, also known as OTX-TKI, our investigational product candidate for retinal disease, is an axitinib intravitreal hydrogel based on our ELUTYX proprietary bioresorbable hydrogel-based formulation technology. AXPAXLI is currently being evaluated in a Phase 3 registrational program for wet age-related macular degeneration, or wet AMD, which we refer to as the SOL program. AXPAXLI is currently ...

Next Earnings

Q2 FY2026 — expected 2026-09-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionOCULdiscussed_in_filing Cybersecurity
topic_mentionOCULdiscussed_in_filing Trusted Computing
topic_mentionOCULdiscussed_in_filing Blockchain & Crypto
topic_mentionOCULdiscussed_in_filing Capital Expenditure
topic_mentionOCULdiscussed_in_filing Supply Chain
topic_mentionOCULdiscussed_in_filing Regulation
topic_mentionOCULdiscussed_in_filing Healthcare & Bio
topic_mentionOCULdiscussed_in_filing Sovereign & Government
topic_mentionOCULdiscussed_in_filing Cybersecurity
topic_mentionOCULdiscussed_in_filing Trusted Computing
topic_mentionOCULdiscussed_in_filing Blockchain & Crypto
topic_mentionOCULdiscussed_in_filing Capital Expenditure
topic_mentionOCULdiscussed_in_filing Supply Chain
topic_mentionOCULdiscussed_in_filing Regulation
topic_mentionOCULdiscussed_in_filing Healthcare & Bio
topic_mentionOCULdiscussed_in_filing Sovereign & Government
topic_mentionOCULdiscussed_in_filing Cybersecurity
topic_mentionOCULdiscussed_in_filing Trusted Computing
topic_mentionOCULdiscussed_in_filing Blockchain & Crypto
topic_mentionOCULdiscussed_in_filing Capital Expenditure

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-052025-12-310001104659-26-010664EDGAR129K words
2025-03-032024-12-310001558370-25-002000EDGAR—
2024-03-112023-12-310001558370-24-002902EDGAR—
2023-03-062022-12-310001558370-23-002908EDGAR—
2022-02-282021-12-310001558370-22-002363EDGAR—
2021-03-112020-12-310001558370-21-002813EDGAR—
2020-03-122019-12-310001558370-20-002537EDGAR—
2019-03-072018-12-310001558370-19-001659EDGAR—
2018-03-082017-12-310001558370-18-001678EDGAR—
2017-03-102016-12-310001558370-17-001627EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001104659-25-105919EDGAR29K words
2025-08-052025-06-300001558370-25-010177EDGAR—
2025-05-052025-03-310001558370-25-006225EDGAR—
2024-11-142024-09-300001558370-24-015613EDGAR—
2024-08-072024-06-300001558370-24-011202EDGAR—
2024-05-072024-03-310001558370-24-007065EDGAR—
2023-11-072023-09-300001558370-23-017989EDGAR—
2023-08-072023-06-300001558370-23-013591EDGAR—
2023-05-082023-03-310001558370-23-008510EDGAR—
2022-11-072022-09-300001558370-22-016610EDGAR—
2022-08-082022-06-300001558370-22-012623EDGAR—
2022-05-092022-03-310001558370-22-007812EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-270001104659-26-021541EDGAR0K words
2026-02-050001104659-26-010633EDGAR—
2026-01-230001104659-26-006015EDGAR—
2025-12-180001104659-25-122564EDGAR—
2025-12-050001104659-25-118940EDGAR—
2025-11-040001104659-25-105914EDGAR—
2025-09-300001104659-25-094758EDGAR—
2025-09-300001104659-25-094724EDGAR—
2025-08-050001104659-25-073909EDGAR—
2025-06-110001104659-25-058525EDGAR—

236 total filings indexed. 204 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001393434
TickerOCUL
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: fc9dbca18fc0623bf08705a47209d96a195605333b40b978b514600c69b984e6
parent: f6bd03419a7ef628f9c199beb6f63ff5fcadb030fea19933ea52b53eb0ca868b
content hash: bf8287fb7fd8c4c7679e903acc2ba46d93d48c51676900ff75035eef4eb528b7
signed: 2026-04-13T04:46:41.093Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf